Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 31 Jul 2025 for Sage Therapeutics, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Michael C. Quirk: trading record in brief
This profile gathers the share dealings of Michael C. Quirk in Sage Therapeutics, Inc. We count 8 filings; the first trade dates from 1 April 2025 and the latest from 31 July 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 31 July 2025, reports a transaction in Sage Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael C. Quirk
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
24,999 sharesCommon StockSEC:0000950170-25-100700:0
113 shares@ US$9.22100.0% of flowCommon StockSEC:0001562180-25-005087:0
933 shares0Common StockSEC:0001562180-25-003113:0
2,000 shares0Common StockSEC:0001562180-25-002905:0
4 of 4 declarations
